ArticleOphthalmology and therapy2025

Multimodal Imaging to Assess Disease Activity and Predict Fluid Resolution in Patients with wAMD Treated with Brolucizumab: The IMAGINE Study.

Marco Lupidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.